BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Matsumoto K, Miyake Y, Miyatake H, Takahara M, Imada T, Yagi S, Toyokawa T, Nakatsu M, Ando M, Hirohata M. A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis B. World J Gastroenterol 2009; 15(13): 1650-1652 [PMID: 19340912 DOI: 10.3748/wjg.15.1650]
URL: https://www.wjgnet.com/1007-9327/full/v15/i13/1650.htm
Number Citing Articles
1
Xin-Yu Liu, Feng Peng, Ya-Jie Pan, Jun Chen. Advanced therapeutic strategies for HBV-related acute-on-chronic liver failureHepatobiliary & Pancreatic Diseases International 2015; 14(4): 354 doi: 10.1016/S1499-3872(15)60338-1
2
Fang Chen, Yuzhi Shi, Xueqin Liu, Lan Lei, Jian Xu. Corticosteroid improves liver function but does not curb the clinical progression of hepatitis B virus-related acute-on-chronic pre-liver failureExpert Review of Gastroenterology & Hepatology 2019; 13(11): 1129 doi: 10.1080/17474124.2019.1688143
3
Hui Zhang, Jianchun Xian, Yang Li, Li Xiao, Lu Wang, Muhammad Zia-Ul-Haq. Effects of Tenofovir Combined with Recombinant Human Interferon α-2b on Negative Conversion Rate, Liver Function, Immune Status, and Drug Safety in Patients with Chronic Hepatitis B: A Systematic Review and Meta-AnalysisEvidence-Based Complementary and Alternative Medicine 2022; 2022: 1 doi: 10.1155/2022/1889628
4
Feng Li, Ying Zhang, Zhao-Hui Wang, Shuai Gao, Yu-Chen Fan, Kai Wang. SOCS1 methylation level is associated with prognosis in patients with acute-on-chronic hepatitis B liver failureClinical Epigenetics 2023; 15(1) doi: 10.1186/s13148-023-01495-9
5
Ke Wang, Zhe-bin Wu, Yi-nong Ye, Jing Liu, Geng-lin Zhang, Yu-jie Su, Hong-liang He, Yu-bao Zheng, Zhi-liang Gao. Plasma Interleukin-10: A Likely Predictive Marker for Hepatitis B Virus-Related Acute-on-Chronic Liver FailureHepatitis Monthly 2014; 14(7) doi: 10.5812/hepatmon.19370
6
Xu‐Qing Zhang, Li Jiang, Jian‐Ping You, Yu‐Yuan Liu, Jing Peng, Hui‐Yan Zhang, Bao‐Yan Xu, Qing Mao. Efficacy of short‐term dexamethasone therapy in acute‐on‐chronic pre‐liver failureHepatology Research 2011; 41(1): 46 doi: 10.1111/j.1872-034X.2010.00740.x
7
Keiichi Fujiwara, Shin Yasui, Koichiro Okitsu, Yutaka Yonemitsu, Shigeto Oda, Osamu Yokosuka. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis BJournal of Gastroenterology 2010; 45(12): 1255 doi: 10.1007/s00535-010-0280-y
8
Ping Fang Hu, Wei Fen Xie. Corticosteroid therapy in drug‐induced liver injury: Pros and consJournal of Digestive Diseases 2019; 20(3): 122 doi: 10.1111/1751-2980.12697
9
Wai‐Kay Seto, Ching‐Lung Lai, Man‐Fung Yuen. Acute‐on‐chronic liver failure in chronic hepatitis BJournal of Gastroenterology and Hepatology 2012; 27(4): 662 doi: 10.1111/j.1440-1746.2011.06971.x
10
Xi Ran, Qiong Fang Zhang, Ling Luo, Da Zhi Zhang, Wei Li. The Efficacy and Safety of Glucocorticoids Plus Conventional Therapy for Hepatitis B-Related Liver Failure in China: A Meta-AnalysisHepatitis Monthly 2019; 19(6) doi: 10.5812/hepatmon.65787
11
Wu Zhe-bin, Wang Ke, Zhi-shuo Mo, Xu Zhen, Zheng Yu-bao, Yan Ying, Gao Zhi-liang. Early, short-term, low-dose glucocorticoid therapy effectively blocks progression of severe acute exacerbation of chronic hepatitis B to liver failureClinics and Research in Hepatology and Gastroenterology 2021; 45(5): 101505 doi: 10.1016/j.clinre.2020.07.010